NOVO.B.DK

305.05

+0.28%↑

GMAB.DK

2,062

+1.88%↑

HLUNB.DK

44.52

+1.32%↑

ZEAL.DK

509.4

+3.33%↑

NOVO.B.DK

305.05

+0.28%↑

GMAB.DK

2,062

+1.88%↑

HLUNB.DK

44.52

+1.32%↑

ZEAL.DK

509.4

+3.33%↑

NOVO.B.DK

305.05

+0.28%↑

GMAB.DK

2,062

+1.88%↑

HLUNB.DK

44.52

+1.32%↑

ZEAL.DK

509.4

+3.33%↑

NOVO.B.DK

305.05

+0.28%↑

GMAB.DK

2,062

+1.88%↑

HLUNB.DK

44.52

+1.32%↑

ZEAL.DK

509.4

+3.33%↑

NOVO.B.DK

305.05

+0.28%↑

GMAB.DK

2,062

+1.88%↑

HLUNB.DK

44.52

+1.32%↑

ZEAL.DK

509.4

+3.33%↑

Search

Coloplast A-S (Class B)

Fermé

584.4 1.21

Résumé

Variation du prix de l'action

24h

Actuel

Min

574.4

Max

585.4

Chiffres clés

By Trading Economics

Revenu

-107M

805M

Ventes

28M

7B

P/E

Moyenne du Secteur

36.506

80.03

BPA

3.88

Rendement du dividende

3.96

Marge bénéficiaire

11.569

Employés

16,744

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.96%

2.29%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-4.1B

133B

Ouverture précédente

583.19

Clôture précédente

584.4

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 déc. 2025, 23:21 UTC

Résultats
Acquisitions, Fusions, Rachats

EQB to Buy Loblaw Unit PC Financial for About $573.5 Million -- Update

3 déc. 2025, 23:14 UTC

Acquisitions, Fusions, Rachats

EQB to Buy PC Financial From Loblaw for About $573.5 Million

3 déc. 2025, 22:01 UTC

Principaux Mouvements du Marché

Costco Wholesale Reports Higher Monthly Sales

3 déc. 2025, 21:38 UTC

Résultats

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 Million

3 déc. 2025, 23:59 UTC

Market Talk

Australian Coal Prices Seen Having Recovered Well -- Market Talk

3 déc. 2025, 23:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 déc. 2025, 23:49 UTC

Market Talk

HSBC Chair Appointment Unlikely to Have Material Operational Impact -- Market Talk

3 déc. 2025, 23:49 UTC

Market Talk

Nikkei May Decline Amid Caution Over U.S. Labor Market -- Market Talk

3 déc. 2025, 23:13 UTC

Market Talk

Australian Treasurer Says Economy Not On Drip of Govt Spending -- Market Talk

3 déc. 2025, 23:10 UTC

Résultats

Salesforce Raises Forecast as Agentforce Sales Top $500M -- Update

3 déc. 2025, 23:08 UTC

Market Talk

Goodman's New Bull Sees Profit Upgrade on Cards -- Market Talk

3 déc. 2025, 23:06 UTC

Acquisitions, Fusions, Rachats

EQB to Buy Loblaw Unit PC Financial for About $573.5M -- Update

3 déc. 2025, 22:59 UTC

Acquisitions, Fusions, Rachats

EQB to Buy PC Financial From Loblaw for About $573.5M

3 déc. 2025, 22:45 UTC

Market Talk

WiseTech Investor Day Increases Bull's Confidence -- Market Talk

3 déc. 2025, 22:20 UTC

Résultats

Salesforce CEO: 9,500 of 18,500 Total Closed Agentforce Deals Are Paid

3 déc. 2025, 22:19 UTC

Résultats

Salesforce CEO: Six Out of 10 Biggest Deals in 3Q Came from Agentforce

3 déc. 2025, 22:17 UTC

Résultats

Salesforce Working to Add Voice to Agentforce, CEO Says

3 déc. 2025, 22:16 UTC

Résultats

Salesforce CEO: Williams-Sonoma's Agentforce Makes Up 60% of Customer Chats

3 déc. 2025, 22:15 UTC

Résultats

Salesforce CEO: Agentforce ARR Was $540M in 3Q

3 déc. 2025, 22:10 UTC

Acquisitions, Fusions, Rachats

EQB: Will Enter Into a Long-Term Strategic Relationship With Loblaw >EQB.T

3 déc. 2025, 22:09 UTC

Acquisitions, Fusions, Rachats

EQB: Agreed to Acquire PC Fincl From Loblaw >EQB.T

3 déc. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

3 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 déc. 2025, 21:49 UTC

Résultats

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

3 déc. 2025, 21:23 UTC

Résultats

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500M

3 déc. 2025, 21:19 UTC

Résultats

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

3 déc. 2025, 21:06 UTC

Résultats

Salesforce Reports Mixed Earnings. The Stock Is Rising. -- Barrons.com

3 déc. 2025, 21:04 UTC

Résultats

Salesforce Sees Profitable Growth Framework Target of 50 by FY30 >CRM

3 déc. 2025, 21:04 UTC

Résultats

Salesforce Targets $60 B Plus Organic Rev by FY30 >CRM

3 déc. 2025, 21:03 UTC

Résultats

Salesforce Raises FY26 Oper Cash Flow Growth Guidance to 13% to 14% Y/Y >CRM

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat